Key result
Aldosterone synthase inhibition shows translational promise in kidney transplantation, though clinical evidence remains limited.
Current evidence insufficient to guide post-transplant care; leaves open the need for prospective trials of aldosterone synthase inhibition.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Corrêa et al. (2026) studied this question. Aldosterone synthase inhibition in kidney transplantation offers translational promise, though current clinical evidence remains limited.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: